<p>三橋財富顧問公司在第二季度購買了丹納赫公司（NYSE:DHR - 免費報告）的新頭寸，根據該公司在最近向證券交易委員會提交的文件。該公司購買了 1,202 股該集團的股票，價值約 238,000 美元。</p>
<ul>
<li>3 只提供強大價值和穩定性的股票</li>
</ul>
<p>其他幾家對沖基金也對 DHR 的頭寸進行了調整。Nuveen LLC 在第一季度購買了價值 833,941,000 美元的丹納赫新股份。Invesco Ltd.在第一季度將其在丹納赫的股份提高了 44.5%。Invesco Ltd.目前擁有 4,708,578 股該集團的股票，價值 965,259,000 美元，此前在上個季度又收購了 1,450,703 股。Baird Financial Group Inc.在第一季度將其在丹納赫的股份提高了 290.6%。Baird Financial Group Inc.目前擁有 1,441,706 股該集團的股票，價值 295,550,000 美元，此前在上個季度又收購了 1,072,617 股。Generation Investment Management LLP 在第一季度將其在丹納赫的股份提高了 33.2%。Generation Investment Management LLP 目前擁有 3,178,124 股該集團的股票，價值 651,515,000 美元，此前在上個季度又收購了 791,662 股。最後，Parnassus Investments LLC 在第一季度將其在丹納赫的股份提高了 23.3%。Parnassus Investments LLC 目前擁有 3,828,024 股該集團的股票，價值 784,745,000 美元，此前在上個季度又收購了 722,636 股。機構投資者持有該公司 79.05% 的股票。</p>
<h2>丹納赫的內部買賣</h2>
<p>在相關消息中，董事 Teri List 於 8 月 22 日星期五出售了 2,778 股該公司的股票。股票以 211.06 美元的平均價格出售，總交易額為 586,324.68 美元。出售完成後，該董事直接持有 20,751 股該公司的股票，價值 4,379,706.06 美元。此次交易使其持股減少了 11.81%。該交易已在向 SEC 的文件中披露，相關信息可在此鏈接查看。公司內部人士目前持有 11.10% 的股票。</p>
<h2>丹納赫股票上漲 2.2%</h2>
<ul>
<li>安捷倫科技受益於對持久性化學品的打擊</li>
</ul>
<p>丹納赫的股票在星期五以 215.05 美元開盤。該公司的市值為 1539.8 億美元，市盈率為 45.75，PEG 比率為 3.06，貝塔值為 0.77。該公司的債務與股本比率為 0.32，速動比率為 1.22，流動比率為 1.62。該公司的 50 日移動平均價格為 200.19 美元，200 日移動平均價格為 197.33 美元。丹納赫公司的 52 周低點為 171.00 美元，52 周高點為 279.41 美元。</p>
<p>丹納赫（NYSE:DHR - 獲取免費報告）最近於 7 月 22 日星期二公佈了季度收益數據。該集團報告本季度每股收益為 1.80 美元，超出分析師一致預期的 1.64 美元，超出幅度為 0.16 美元。該公司本季度的收入為 59.4 億美元，而分析師預期為 58.3 億美元。丹納赫的股本回報率為 10.70%，淨利潤率為 14.21%。該公司的季度收入較去年同期增長了 3.4%。去年同期，該公司每股收益為 1.72 美元。丹納赫已將其 2025 財年的指引設定為每股收益 7.700-7.800 美元。分析師平均預測丹納赫公司今年的每股收益為 7.63 美元。</p>
<h2>丹納赫宣佈分紅</h2>
<ul>
<li>丹納赫股票在 2024 年會創下新高嗎？</li>
</ul>
<p>該公司最近還宣佈了一項季度分紅，將於 10 月 31 日星期五支付。9 月 26 日星期五的登記投資者將獲得每股 0.32 美元的分紅。這相當於年化分紅為 1.28 美元，分紅收益率為 0.6%。該分紅的除息日為 9 月 26 日星期五。丹納赫的派息比率為 27.23%。</p>
<h2>華爾街分析師的看法</h2>
<p>一些研究公司最近對 DHR 發表了評論。Robert W. Baird 在 7 月 18 日的研究報告中將丹納赫的目標價從 225.00 美元上調至 226.00 美元，並給予該股票 “跑贏大盤” 的評級。Evercore ISI 在 7 月 8 日的報告中將丹納赫的目標價從 230.00 美元下調至 226.00 美元，並對該股票設定了 “跑贏大盤” 的評級。Scotiabank 在 7 月 11 日的報告中將丹納赫的評級從 “行業表現” 上調至 “行業跑贏大盤”，並設定了 275.00 美元的目標價。Weiss Ratings 在 9 月 27 日的研究報告中重新發布了對丹納赫股票的 “持有（c-）” 評級。最後，巴克萊在 6 月 24 日的研究報告中重申了 “增持” 評級，並將丹納赫股票的目標價設定為 225.00 美元（之前為 215.00 美元）。十七位分析師對該股票給予了買入評級，四位分析師對該股票給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，共識目標價為 245.91 美元。</p>
<p><strong>獲取我們最新的丹納赫股票分析</strong></p>
<h2>丹納赫公司簡介</h2>
<p>（免費報告）</p>
<p>丹納赫公司在全球範圍內設計、製造和銷售專業、醫療、工業和商業產品及服務。生物技術部門提供生物處理技術、耗材和服務，以推進、加速和整合治療藥物的開發和生產；細胞系和細胞培養基開發服務；用於製造的細胞培養基、工藝液體和緩衝液；色譜樹脂、過濾技術、無菌灌裝；一次性硬件和耗材及服務，如完整製造套件的設計和安裝；實驗室過濾、分離和純化；實驗室規模的蛋白質純化和分析工具；試劑、膜和服務；以及醫療過濾解決方案。</p>
<h2>特色故事</h2>
<ul>
<li>五隻我們認為比丹納赫更好的股票</li>
<li>什麼是看跌期權成交量？</li>
<li>為什麼沒人談論的貴金屬可能是你最好的投資選擇</li>
<li>期權交易 - 理解行使價格</li>
<li>便宜的 Chipotle？為什麼 CMG 股票可能準備反彈</li>
<li>FAANG 股票是什麼，它們是好的投資嗎？</li>
<li>三隻準備受益於美聯儲降息和支出的工業股票</li>
</ul>
<p><strong>想看看其他對 DHR 感興趣的對沖基金持有哪些股票嗎？</strong> 訪問 HoldingsChannel.com 獲取丹納赫公司（NYSE:DHR - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在丹納赫嗎？</h2>
<p>在考慮丹納赫之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而丹納赫並不在名單上。</p>
<p>雖然丹納赫目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

丹納赫

<p>Three Bridge Wealth Advisors LLC 在第二季度投資了 238,000 美元于丹納赫公司（NYSE:DHR），購買了 1,202 股。其他機構投資者也增加了在丹納赫的持股，其中 Nuveen LLC 和 Invesco Ltd.的增持尤為顯著。丹納赫最近報告的季度每股收益為 1.80 美元，超出預期，並宣佈每股季度分紅為 0.32 美元。該股票目前交易價格為 215.05 美元，市值為 1,539.8 億美元，股息收益率為 0.6%</p>

<p>Three Bridge Wealth Advisors LLC bought a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 1,202 shares of the conglomerate's stock, valued at approximately $238,000.</p>
<div class="lb-trans"><p>三橋財富顧問公司在第二季度購買了丹納赫公司（NYSE:DHR - 免費報告）的新頭寸，根據該公司在最近向證券交易委員會提交的文件。該公司購買了 1,202 股該集團的股票，價值約 238,000 美元。</p>
</div><ul>
<li>3 Stocks Offering Strong Value and Stability</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提供強大價值和穩定性的股票</li>
</ul>
</div><p>Several other hedge funds have also made changes to their positions in DHR. Nuveen LLC bought a new stake in Danaher during the 1st quarter valued at $833,941,000. Invesco Ltd. raised its stake in Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock valued at $965,259,000 after acquiring an additional 1,450,703 shares in the last quarter. Baird Financial Group Inc. raised its stake in Danaher by 290.6% during the 1st quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate's stock valued at $295,550,000 after acquiring an additional 1,072,617 shares in the last quarter. Generation Investment Management LLP raised its stake in Danaher by 33.2% during the 1st quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate's stock valued at $651,515,000 after acquiring an additional 791,662 shares in the last quarter. Finally, Parnassus Investments LLC raised its stake in Danaher by 23.3% during the 1st quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate's stock valued at $784,745,000 after acquiring an additional 722,636 shares in the last quarter. Institutional investors own 79.05% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家對沖基金也對 DHR 的頭寸進行了調整。Nuveen LLC 在第一季度購買了價值 833,941,000 美元的丹納赫新股份。Invesco Ltd.在第一季度將其在丹納赫的股份提高了 44.5%。Invesco Ltd.目前擁有 4,708,578 股該集團的股票，價值 965,259,000 美元，此前在上個季度又收購了 1,450,703 股。Baird Financial Group Inc.在第一季度將其在丹納赫的股份提高了 290.6%。Baird Financial Group Inc.目前擁有 1,441,706 股該集團的股票，價值 295,550,000 美元，此前在上個季度又收購了 1,072,617 股。Generation Investment Management LLP 在第一季度將其在丹納赫的股份提高了 33.2%。Generation Investment Management LLP 目前擁有 3,178,124 股該集團的股票，價值 651,515,000 美元，此前在上個季度又收購了 791,662 股。最後，Parnassus Investments LLC 在第一季度將其在丹納赫的股份提高了 23.3%。Parnassus Investments LLC 目前擁有 3,828,024 股該集團的股票，價值 784,745,000 美元，此前在上個季度又收購了 722,636 股。機構投資者持有該公司 79.05% 的股票。</p>
</div><h2>Insider Buying and Selling at Danaher</h2>
<div class="lb-trans"><h2>丹納赫的內部買賣</h2>
</div><p>In related news, Director Teri List sold 2,778 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 11.10% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相關消息中，董事 Teri List 於 8 月 22 日星期五出售了 2,778 股該公司的股票。股票以 211.06 美元的平均價格出售，總交易額為 586,324.68 美元。出售完成後，該董事直接持有 20,751 股該公司的股票，價值 4,379,706.06 美元。此次交易使其持股減少了 11.81%。該交易已在向 SEC 的文件中披露，相關信息可在此鏈接查看。公司內部人士目前持有 11.10% 的股票。</p>
</div><h2>Danaher Stock Up 2.2%</h2>
<div class="lb-trans"><h2>丹納赫股票上漲 2.2%</h2>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷倫科技受益於對持久性化學品的打擊</li>
</ul>
</div><p>Shares of DHR opened at $215.05 on Friday. The firm has a market capitalization of $153.98 billion, a price-to-earnings ratio of 45.75, a PEG ratio of 3.06 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The business's fifty day moving average price is $200.19 and its two-hundred day moving average price is $197.33. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.41.</p>
<div class="lb-trans"><p>丹納赫的股票在星期五以 215.05 美元開盤。該公司的市值為 1539.8 億美元，市盈率為 45.75，PEG 比率為 3.06，貝塔值為 0.77。該公司的債務與股本比率為 0.32，速動比率為 1.22，流動比率為 1.62。該公司的 50 日移動平均價格為 200.19 美元，200 日移動平均價格為 197.33 美元。丹納赫公司的 52 周低點為 171.00 美元，52 周高點為 279.41 美元。</p>
</div><p>Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period last year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.</p>
<div class="lb-trans"><p>丹納赫（NYSE:DHR - 獲取免費報告）最近於 7 月 22 日星期二公佈了季度收益數據。該集團報告本季度每股收益為 1.80 美元，超出分析師一致預期的 1.64 美元，超出幅度為 0.16 美元。該公司本季度的收入為 59.4 億美元，而分析師預期為 58.3 億美元。丹納赫的股本回報率為 10.70%，淨利潤率為 14.21%。該公司的季度收入較去年同期增長了 3.4%。去年同期，該公司每股收益為 1.72 美元。丹納赫已將其 2025 財年的指引設定為每股收益 7.700-7.800 美元。分析師平均預測丹納赫公司今年的每股收益為 7.63 美元。</p>
</div><h2>Danaher Announces Dividend</h2>
<div class="lb-trans"><h2>丹納赫宣佈分紅</h2>
</div><ul>
<li>Will Danaher stock hit new highs in 2024?</li>
</ul>
<div class="lb-trans"><ul>
<li>丹納赫股票在 2024 年會創下新高嗎？</li>
</ul>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's payout ratio is 27.23%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，將於 10 月 31 日星期五支付。9 月 26 日星期五的登記投資者將獲得每股 0.32 美元的分紅。這相當於年化分紅為 1.28 美元，分紅收益率為 0.6%。該分紅的除息日為 9 月 26 日星期五。丹納赫的派息比率為 27.23%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師的看法</h2>
</div><p>A number of research firms have recently commented on DHR. Robert W. Baird boosted their price objective on Danaher from $225.00 to $226.00 and gave the stock an &#34;outperform&#34; rating in a research note on Friday, July 18th. Evercore ISI lowered their price target on Danaher from $230.00 to $226.00 and set an &#34;outperform&#34; rating on the stock in a report on Tuesday, July 8th. Scotiabank upgraded Danaher from a &#34;sector perform&#34; rating to a &#34;sector outperform&#34; rating and set a $275.00 price target on the stock in a report on Friday, July 11th. Weiss Ratings reissued a &#34;hold (c-)&#34; rating on shares of Danaher in a research report on Saturday, September 27th. Finally, Barclays reiterated an &#34;overweight&#34; rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Seventeen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $245.91.</p>
<div class="lb-trans"><p>一些研究公司最近對 DHR 發表了評論。Robert W. Baird 在 7 月 18 日的研究報告中將丹納赫的目標價從 225.00 美元上調至 226.00 美元，並給予該股票 “跑贏大盤” 的評級。Evercore ISI 在 7 月 8 日的報告中將丹納赫的目標價從 230.00 美元下調至 226.00 美元，並對該股票設定了 “跑贏大盤” 的評級。Scotiabank 在 7 月 11 日的報告中將丹納赫的評級從 “行業表現” 上調至 “行業跑贏大盤”，並設定了 275.00 美元的目標價。Weiss Ratings 在 9 月 27 日的研究報告中重新發布了對丹納赫股票的 “持有（c-）” 評級。最後，巴克萊在 6 月 24 日的研究報告中重申了 “增持” 評級，並將丹納赫股票的目標價設定為 225.00 美元（之前為 215.00 美元）。十七位分析師對該股票給予了買入評級，四位分析師對該股票給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，共識目標價為 245.91 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Danaher</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的丹納赫股票分析</strong></p>
</div><h2>Danaher Company Profile</h2>
<div class="lb-trans"><h2>丹納赫公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p>
<div class="lb-trans"><p>丹納赫公司在全球範圍內設計、製造和銷售專業、醫療、工業和商業產品及服務。生物技術部門提供生物處理技術、耗材和服務，以推進、加速和整合治療藥物的開發和生產；細胞系和細胞培養基開發服務；用於製造的細胞培養基、工藝液體和緩衝液；色譜樹脂、過濾技術、無菌灌裝；一次性硬件和耗材及服務，如完整製造套件的設計和安裝；實驗室過濾、分離和純化；實驗室規模的蛋白質純化和分析工具；試劑、膜和服務；以及醫療過濾解決方案。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>特色故事</h2>
</div><ul>
<li>Five stocks we like better than Danaher</li>
<li>What is Put Option Volume?</li>
<li>Why the Precious Metal Nobody Talks About Could Be Your Best Bet</li>
<li>Options Trading - Understanding Strike Price</li>
<li>Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback</li>
<li>What Are the FAANG Stocks and Are They Good Investments?</li>
<li>3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比丹納赫更好的股票</li>
<li>什麼是看跌期權成交量？</li>
<li>為什麼沒人談論的貴金屬可能是你最好的投資選擇</li>
<li>期權交易 - 理解行使價格</li>
<li>便宜的 Chipotle？為什麼 CMG 股票可能準備反彈</li>
<li>FAANG 股票是什麼，它們是好的投資嗎？</li>
<li>三隻準備受益於美聯儲降息和支出的工業股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding DHR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 DHR 感興趣的對沖基金持有哪些股票嗎？</strong> 訪問 HoldingsChannel.com 獲取丹納赫公司（NYSE:DHR - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=DHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Danaher Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在丹納赫嗎？</h2>
</div><p>Before you consider Danaher, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮丹納赫之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而丹納赫並不在名單上。</p>
</div><p>While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然丹納赫目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Three Bridge Wealth Advisors LLC 向丹納赫公司$DHR 投資了 23.8 萬美元